相关实验视频
Updated: Nov 12, 2025

15:15
Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
35.0K
在克隆性血液形成中,AIM2炎症酶会加剧动脉样硬化
Trevor P Fidler1, Chenyi Xue2,3, Mustafa Yalcinkaya4
1Division of Molecular Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA. tpf2103@cumc.columbia.edu.
Nature
|March 18, 2021
概括
由JAK2V617F等突变驱动的克隆性血液形成,通过增加巨细胞的增殖和炎症酶激活来加速动脉样硬化. 针对炎症体或白蛋白-1β可能会降低心血管风险.
科学领域:
- 心血管研究
- 血液学
- 免疫学
背景情况:
- 克隆性血液形成在老年人中很常见,并增加心血管风险.
- 这种JAK2V617F突变与早发冠心病有关.
- 将克隆性血液形成与动脉样硬化的机制需要进一步阐明.
研究的目的:
- 研究JAK2V617F驱动的克隆性血液形成在动脉样硬化中的作用.
- 在此背景下确定调解心血管风险的分子途径.
- 探索潜在的治疗目标.
主要方法:
- 在巨细胞中表达Jak2VF的小鼠模型和模拟克隆性血液形成的仿真小鼠模型.
- 炎症组分的遗传删除 (酶1,11,气皮D) 和AIM2.
- 动脉样损伤的单细胞RNA测序
- 抑制介质蛋白-1β.
主要成果:
- 在动脉样硬化病变中,Jak2VF表达增加了巨细胞的增殖和死核的形成.
- 删除炎症组件或气皮D可以逆转这些不良反应.
- 雅克2VF病变显示AIM2表达增加,DNA损伤和复制压力;Aim2缺乏减少了动脉样硬化.
- 通过减少死细胞的形成和增加纤维状盖子来稳定interleukin-1β的抑制.
结论:
- 在Jak2VF巨细胞中增加的增殖和变化的代谢导致DNA复制压力和AIM2炎症酶激活,从而加剧动脉样硬化.
- 针对炎症体通路,特别是介质蛋白-1β,提供了一种潜在的策略,以减轻与克隆性血液形成相关的心血管风险.
相关概念视频
Myocarditis I: Introduction
143
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
143
Inflammation
57.5K
Overview
57.5K
Regulation of Hematopoietic Stem Cells
3.6K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K
Atherosclerosis I: Introduction
336
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
336
Coronary Artery Disease II: Pathophysiology
165
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
165
Inflammatory Response I: Vascular and Cellular
14.0K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
14.0K

